In vitro experiments revealed that the three NFFs obtained from three independent neurofibromatosis 1 patients exhibited point mutations of the NF1 gene, which result in reduced NF1 protein expression compared with that in HEFs established from healthy volunteers. The gene discussed is NF1; the disease is neurofibromatosis type 1.